Literature DB >> 23534382

Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity.

Riccardo Torosantucci1, Victor S Sharov, Miranda van Beers, Vera Brinks, Christian Schöneich, Wim Jiskoot.   

Abstract

Oxidation via Cu(2+)/ascorbate of recombinant human interferon beta-1a (IFNβ1a) leads to highly immunogenic aggregates, however it is unknown which amino acids are modified and how covalent aggregates are formed. In the present work we mapped oxidized and cross-linked amino acid residues in aggregated IFNβ1a, formed via Cu(2+)/ascorbate catalyzed oxidation. Size exclusion chromatography (SEC) was used to confirm extensive aggregation of oxidized IFNβ1a. Circular dichroism and intrinsic fluorescence spectroscopy indicated substantial loss of secondary and tertiary structure, respectively. Derivatization with 4-(aminomethyl)benzenesulfonic acid was used to demonstrate, by fluorescence in combination with SEC, the presence of tyrosine (Tyr) oxidation products. High performance liquid chromatography coupled to electrospray ionization mass spectrometry of reduced, alkylated, and digested protein was employed to localize chemical degradation products. Oxidation products of methionine, histidine, phenylalanine (Phe), tryptophan, and Tyr residues were identified throughout the primary sequence. Covalent cross-links via 1,4- or 1,6-type addition between primary amines and DOCH (2-amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid, an oxidation product of Phe and Tyr) were detected. There was no evidence of disulfide bridge, Schiff base, or dityrosine formation. The chemical cross-links identified in this work are most likely responsible for the formation of covalent aggregates of IFNβ1a induced by oxidation, which have previously been shown to be highly immunogenic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534382      PMCID: PMC3736809          DOI: 10.1021/mp300665u

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  49 in total

1.  Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins.

Authors:  Steven W Taylor; Eoin Fahy; James Murray; Roderick A Capaldi; Soumitra S Ghosh
Journal:  J Biol Chem       Date:  2003-04-04       Impact factor: 5.157

2.  n-Dodecyl-β-D-maltoside inhibits aggregation of human interferon-β-1b and reduces its immunogenicity.

Authors:  Robert A Rifkin; Edward T Maggio; Sonny Dike; Douglas A Kerr; Michael Levy
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-08       Impact factor: 4.147

3.  Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

Authors:  L Runkel; W Meier; R B Pepinsky; M Karpusas; A Whitty; K Kimball; M Brickelmaier; C Muldowney; W Jones; S E Goelz
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Computed circular dichroism spectra for the evaluation of protein conformation.

Authors:  N Greenfield; G D Fasman
Journal:  Biochemistry       Date:  1969-10       Impact factor: 3.162

5.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

6.  Dityrosine: a marker for oxidatively modified proteins and selective proteolysis.

Authors:  C Giulivi; K J Davies
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice.

Authors:  Miranda M C van Beers; Melody Sauerborn; Francesca Gilli; Vera Brinks; Huub Schellekens; Wim Jiskoot
Journal:  Pharm Res       Date:  2011-05-05       Impact factor: 4.200

8.  MassMatrix: a database search program for rapid characterization of proteins and peptides from tandem mass spectrometry data.

Authors:  Hua Xu; Michael A Freitas
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

Review 9.  Diagnosis and management of multiple sclerosis.

Authors:  Peter A Calabresi
Journal:  Am Fam Physician       Date:  2004-11-15       Impact factor: 3.292

10.  Site-specific oxidation of histidine residues in glycated insulin mediated by Cu2+.

Authors:  R Z Cheng; S Kawakishi
Journal:  Eur J Biochem       Date:  1994-08-01
View more
  16 in total

Review 1.  Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective.

Authors:  Anas M Fathallah; Richard B Bankert; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2013-07-16       Impact factor: 4.009

Review 2.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  Facile imprinted polymer for label-free highly selective potentiometric sensing of proteins: case of recombinant human erythropoietin.

Authors:  Ahmed H Nadim; May A Abd El-Aal; Medhat A Al-Ghobashy; Yasser S El-Saharty
Journal:  Anal Bioanal Chem       Date:  2021-04-17       Impact factor: 4.142

4.  Chemical and Biophysical Characteristics of Monoclonal Antibody Solutions Containing Aggregates Formed during Metal Catalyzed Oxidation.

Authors:  Linda O Narhi; Quanzhou Luo; Jette Wypych; Riccardo Torosantucci; Andrea Hawe; Kiyoshi Fujimori; Yasser Nashed-Samuel; Vibha Jawa; Marisa K Joubert; Wim Jiskoot
Journal:  Pharm Res       Date:  2017-11-06       Impact factor: 4.200

Review 5.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

6.  Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.

Authors:  A Dicitore; E S Grassi; M O Borghi; G Gelmini; M C Cantone; G Gaudenzi; L Persani; M Caraglia; G Vitale
Journal:  J Endocrinol Invest       Date:  2017-03-01       Impact factor: 4.256

7.  Metal-mediated protein oxidation: applications of a modified ELISA-based carbonyl detection assay for complex proteins.

Authors:  Hiroshi Uehara; V Ashutosh Rao
Journal:  Pharm Res       Date:  2014-09-03       Impact factor: 4.200

8.  Effect of Chemical Oxidation on the Higher Order Structure, Stability, Aggregation, and Biological Function of Interferon Alpha-2a: Role of Local Structural Changes Detected by 2D NMR.

Authors:  Dinen D Shah; Surinder M Singh; Krishna M G Mallela
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

9.  Nanoparticulate Impurities Isolated from Pharmaceutical-Grade Sucrose Are a Potential Threat to Protein Stability.

Authors:  Daniel Weinbuch; Mitchel Ruigrok; Wim Jiskoot; Andrea Hawe
Journal:  Pharm Res       Date:  2017-10-24       Impact factor: 4.200

10.  Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Andre L Samson; Anja S Knaupp; Itamar Kass; Oded Kleifeld; Emilia M Marijanovic; Victoria A Hughes; Chris J Lupton; Ashley M Buckle; Stephen P Bottomley; Robert L Medcalf
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.